\documentclass[10pt,letterpaper]{article}
\usepackage[margin=0.5in]{geometry}
\usepackage{enumitem}
\usepackage{hyperref}
\usepackage{titlesec}
\usepackage{xcolor}
% \usepackage[colorlinks=true]{hyperref}
% \usepackage{tgheros}%lmodern}      % helvet
\usepackage{arimo}

\renewcommand{\familydefault}{\sfdefault}
\usepackage{titlecaps}


% Remove page numbers
\pagestyle{empty}

% Adjust spacing
\setlength{\parindent}{0pt}
\setlength{\topsep}{-2pt}
\setlength{\parskip}{-2pt}
\titlespacing{\section}{0pt}{4pt}{1pt}
\titlespacing{\subsection}{0pt}{0pt}{0pt}
\linespread{0.95}   % try 0.9 to 0.95 and see what you like

% Section formatting
\titleformat{\section}{\bfseries\uppercase}{}{0pt}{}[\titlerule]
\titleformat{\subsection}[runin]{\bfseries}{}{0pt}{}


% Custom commands for easy updates
\newcommand{\name}{Kathryn Monopoli}
\newcommand{\phone}{+1-508-367-9077}
\newcommand{\email}{krmonopoli@gmail.com}
\newcommand{\linkedin}{linkedin.com/in/kathrynmonopoli}
\newcommand{\website}{https://kmonopoli.github.io/}
\newcommand{\googlescholar}{https://scholar.google.com/citations?hl=en&user=fYt4EYcAAAAJ&view_op=list_works&sortby=pubdate}



% ============================================
% HEADLINE VARIANTS - UNCOMMENT ONE
% ============================================

% Option 1: RNA Therapeutics Focused (CURRENT)
\newcommand{\headline}{%
\textit{\small{
Adaptable computational scientist with expertise in machine learning and high-throughput analysis. Proven track record developing models for therapeutic applications and efficient pipelines for data processing. Prior bench experience enables cross-team communication and informed data analysis and validation.}}
}

% Option 2: Machine Learning / Data Science Focused
% \newcommand{\headline}{%
% Machine learning scientist with 10+ years programming experience and expertise in developing predictive models for biological applications. Strong track record building production-ready ML pipelines and translating complex analyses into actionable insights. Skilled at bridging computational and experimental teams through clear communication.
% }

% Option 3: Bioinformatics Focused
% \newcommand{\headline}{%
% Computational biologist specializing in sequence analysis, NGS data pipelines, and machine learning applications in drug discovery. Combines deep biological knowledge with strong software development skills to solve complex problems in therapeutic development. Experienced collaborating across computational and wet-lab teams.
% }

% Option 4: Generalist Biotech Data Science
% \newcommand{\headline}{%
% Data scientist with interdisciplinary expertise spanning machine learning, bioinformatics, and therapeutic development. Proven ability to develop predictive models, build data pipelines, and communicate complex results to diverse stakeholders. Track record delivering impact in both academic and biotech industry settings.
% }

\begin{document}
# KATHRYN MONOPOLI

**Phone:** +1-508-367-9077 | **Email:** krmonopoli@gmail.com  
**LinkedIn:** linkedin.com/in/kathrynmonopoli | **Website:** https://kmonopoli.github.io/

---

## PROFESSIONAL SUMMARY

Computational scientist specializing in AI/ML for RNA therapeutics with proven impact in siRNA design and drug discovery. Developed predictive models enabling design of 2,000+ potent therapeutic siRNAs, with 34 advancing to drug discovery pipelines. Expert in combining deep learning, feature engineering, and RNA biology to solve complex therapeutic challenges. Strong track record of cross-functional collaboration, project leadership, and translating computational insights into experimental success.

---

## CORE COMPETENCIES

**RNA Therapeutics:** siRNA design & optimization • RNAi mechanisms • Chemical modifications • ASOs • Self-deliverable oligonucleotides • Off-target prediction • Potency enhancement • Strand selection

**Machine Learning/AI:** TensorFlow • PyTorch • Scikit-learn • Deep learning • Novel embedding methods • Feature engineering • Predictive modeling • Model optimization • Transfer learning • Ensemble methods

**Technical Skills:** Python (10+ yrs) • R • NGS data pipelines • High-throughput screening analysis • AWS • Docker • Git • SQL • Biopython • Statistical modeling

**Drug Discovery:** Therapeutic target selection • Lead optimization • Structure-activity relationships • Dose-response modeling • In silico design • Translational research

---

## PROFESSIONAL EXPERIENCE

### Graduate Researcher, Bioinformatics | UMass Chan Medical School, Worcester, MA
**2019 – 2025**

- **Pioneered AI/ML framework for therapeutic siRNA design**, directing creation of 2,000+ highly potent fully modified siRNAs with 34 currently in active drug discovery and therapeutic development programs across multiple disease areas
- **Developed novel deep learning embedding method** capturing transcriptome-wide sequence relationships, achieving **5-fold improvement in siRNA potency prediction accuracy** over previous approaches
- **Built end-to-end ML pipelines** for high-throughput NGS data processing, feature extraction, model training, and validation ensuring reproducibility and accuracy across diverse therapeutic programs
- **Led cross-functional software development project** as technical PM, managing engineering team to deploy ML models in production web application for siRNA design; coordinated across computational, experimental, and engineering teams
- **Applied advanced ML techniques** including ensemble methods, gradient boosting, regularized models, and custom neural architectures with rigorous cross-validation strategies for limited biological datasets
- **Designed and optimized features** from RNA sequence, structure, and transcriptomic data; developed novel approaches for multi-feature interactions and chemical modification pattern analysis
- **Contributed to 4 patent applications** for oligonucleotide therapeutics targeting neurological diseases and SARS-CoV-2
- **Authored/co-authored multiple high-impact publications** including manuscript in preparation for Nature Biotechnology on advanced AI methods for siRNA design

**Key Projects:**
- Tau/MAPT siRNA therapeutics for Alzheimer's disease
- SNCA/α-synuclein targeting for Parkinson's disease
- MSH3 targeting for Huntington's disease
- SARS-CoV-2 antiviral oligonucleotide therapeutics

### Associate Scientist, Bioinformatics | Advirna, Cambridge, MA
**2016 – 2018**

- **Improved siRNA design algorithm**, increasing therapeutic design throughput **5-fold** while maintaining high predicted efficacy
- **Developed interpretable ML model** for siRNA potency prediction using regularized linear approaches optimized for limited training data typical in early-stage therapeutic programs
- **Built and deployed MySQL database system** with cloud-based web interface for oligonucleotide data management, streamlining access across R&D teams and reducing operational costs

### Researcher, Computational Biophysics | Institute for Protein Design (Baker Lab), Seattle, WA
**2016**

- **Implemented entropy modeling component** in Rosetta protein folding software suite (C++)
- **Executed large-scale molecular modeling** utilizing high-throughput cloud computing infrastructure

### Intern, Antibody Discovery | Biogen, Cambridge, MA
**2013**

- **Characterized therapeutic monoclonal antibodies** using BLI and ELISA for binding, stability, and functionality
- **Developed Python-based computational parser** for antigen-binding site analysis, accelerating epitope mapping workflows

---

## EDUCATION

**PhD, Computational Biosciences & Bioengineering**  
UMass Chan Medical School & Worcester Polytechnic Institute | **November 2025**  
Advisors: Anastasia Khvorova (RNA Therapeutics Institute), Dmitry Korkin (Bioinformatics & CS)  
*Thesis: Advanced machine learning methods for therapeutic fully modified siRNA design*

**MS, Molecular and Cellular Biology** | University of Massachusetts Amherst | **2015**  
Phi Beta Kappa, GPA 4.0

**BS, Biochemistry & Molecular Biology** | University of Massachusetts Amherst | **2014**  
Honors College, *summa cum laude*, GPA 4.0

---

## SELECTED PUBLICATIONS

- **Monopoli KR**, Sostek B, Gross K, Alterman J, Korkin D, Khvorova A. (2025) Applying advanced artificial intelligence methods to define features of functional therapeutic siRNAs. *In preparation for Nature Biotechnology.*

- Davis SM, Hildebrand S, **Monopoli KR**, et al. (2025) Systematic Analysis of siRNA and mRNA Features Impacting Fully Chemically Modified siRNA Efficacy. *Nucleic Acids Research*.

- **Monopoli KR**, Korkin D, Khvorova A. (2023) Asymmetric trichotomous data partitioning enables development of predictive machine learning models using limited siRNA efficacy datasets. *Molecular Therapy: Nucleic Acids*.

- Shmushkovich T*, **Monopoli KR***, et al. (2018) Functional features defining the efficacy of cholesterol-conjugated self-deliverable chemically modified siRNAs. *Nucleic Acids Research*. *co-first authors

**Full publication list:** https://scholar.google.com/citations?user=fYt4EYcAAAAJ

---

## PATENTS

- Oligonucleotides for MAPT modulation (US 17/204,480)
- Oligonucleotides for SNCA modulation (US 17/204,483)
- Oligonucleotides for MSH3 modulation (US 63/012,603)
- Oligonucleotides for SARS-CoV-2 modulation (US 17/333,839)

---

## SELECTED PRESENTATIONS

- **Invited Speaker**, American Society of Gene & Cell Therapy (ASGCT), Boston, MA (May 2026)
- **Oral Presentation**, Oligonucleotide Therapeutics Society (OTS), Budapest, Hungary (Oct 2025)
- **Oral Presentation**, Cold Spring Harbor Laboratory Nucleic Acid Therapies (Mar 2025)
- **Oral Presentation**, Intelligent Systems for Molecular Biology (ISMB), Madison, WI (Jul 2022)
- **Invited Speaker**, Oligonucleotide Therapeutics Society Webinar (Oct 2021)

---

## LEADERSHIP & MANAGEMENT

**Software Development Project Manager** | UMass Chan Medical School | 2023–2025
- Managed full software development lifecycle for ML-powered siRNA design platform
- Led recruitment, hiring, and onboarding of engineering team; coordinated funding and payroll
- Mentored junior engineer and facilitated cross-team communication ensuring timely deliverables

---

*References available upon request*
\end{document}